{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T21:40:28Z","timestamp":1733953228459,"version":"3.30.2"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.micpath.2024.107092","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T23:59:09Z","timestamp":1730937549000},"page":"107092","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Can distinct Gram-negative biofilm-forming bacteria have different impacts on ciprofloxacin lung penetration?"],"prefix":"10.1016","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6513-0381","authenticated-orcid":false,"given":"Graziela de Ara\u00fajo","family":"Lock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vict\u00f3ria Etges","family":"Helfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-5263","authenticated-orcid":false,"given":"Bruna Bernar","family":"Dias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiano","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9227-2991","authenticated-orcid":false,"given":"Teresa","family":"Dalla Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bibiana Verlindo","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2024","series-title":"Bacterial Pneumonia","author":"Sattar","key":"10.1016\/j.micpath.2024.107092_bib1"},{"key":"10.1016\/j.micpath.2024.107092_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000487515","article-title":"Pseudomonas aeruginosa and Klebsiella pneumoniae adaptation to innate immune clearance mechanisms in the lung","volume":"10","author":"Riquelme","year":"2018","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.micpath.2024.107092_bib3","article-title":"Clinical and microbiological characteristics of bacteremic pneumonia caused by Klebsiella pneumoniae","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2024.107092_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01190-2017","article-title":"Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients","volume":"52","author":"Restrepo","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.micpath.2024.107092_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7573\/dic.212527","article-title":"How to manage Pseudomonas aeruginosa infections","volume":"7","author":"Bassetti","year":"2018","journal-title":"Drugs Context"},{"year":"2024","series-title":"Klebsiella Pneumonia, StatPearls Publishing LCC.","author":"Ashurst","key":"10.1016\/j.micpath.2024.107092_bib6"},{"key":"10.1016\/j.micpath.2024.107092_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.coph.2017.09.019","article-title":"Considerations for effect site pharmacokinetics to estimate drug exposure: concentrations of antibiotics in the lung","volume":"36","author":"Rodvold","year":"2017","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107092_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228671","article-title":"Pseudomonas aeruginosa biofilms","volume":"21","author":"Thi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2024.107092_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/mdr.2014.0024","article-title":"Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant pseudomonas aeruginosa mature biofilm using in vitro experimental model","volume":"20","author":"Elkhatib","year":"2014","journal-title":"Microb. Drug Resist."},{"author":"Roy","key":"10.1016\/j.micpath.2024.107092_bib10"},{"key":"10.1016\/j.micpath.2024.107092_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.addr.2014.11.017","article-title":"Antimicrobial resistance , respiratory tract infections and role of bio fi lms in lung infections in cystic fi brosis patients","volume":"85","author":"Ciofu","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2024.107092_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/AAC.47.1.317-323.2003","article-title":"Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin","volume":"47","author":"Walters","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107092_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2005.01.025","article-title":"Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters","volume":"510","author":"Ueyama","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.micpath.2024.107092_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081156","article-title":"No time dependence of ciprofloxacin pharmacokinetics in critically ill adults: comparison of individual and population analyses","volume":"13","author":"\u0160\u00edma","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.micpath.2024.107092_bib15","first-page":"2535","article-title":"Ciprofloxacin is actively transported across bronchial lung epithelial cells using a calu-3 air interface cell","volume":"57","author":"Ong","year":"2013","journal-title":"Model"},{"key":"10.1016\/j.micpath.2024.107092_bib16","first-page":"543","volume":"vol. 54","author":"Brillault","year":"2010"},{"key":"10.1016\/j.micpath.2024.107092_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.ejps.2018.11.007","article-title":"Population pharmacokinetic modeling to establish the role of P-glycoprotein on ciprofloxacin distribution to lung and prostate following intravenous and intratracheal administration to Wistar rats","volume":"127","author":"Zimmermann","year":"2019","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.micpath.2024.107092_bib18","first-page":"99","volume":"7","author":"Petrovic","year":"2007","journal-title":"Micheline Piquette-Miller"},{"key":"10.1016\/j.micpath.2024.107092_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.02553-16","article-title":"Population pharmacokinetic modeling as a tool to characterize the decrease in ciprofloxacin free interstitial levels caused by Pseudomonas aeruginosa biofilm lung infection in wistar rats","volume":"61","author":"Torres","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2024.107092_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106546","article-title":"Population pharmacokinetic modeling of the influence of chronic and acute biofilm-forming Pseudomonas aeruginosa lung infection on ciprofloxacin free pulmonary and epithelial lining fluid concentrations","volume":"189","author":"Lock","year":"2023","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.micpath.2024.107092_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chroma.2017.09.036","article-title":"Development and validation of a high-throughput method for determination of nine fluoroquinolones residues in muscle of different animal species by liquid chromatography coupled to tandem mass spectrometry with low temperature clean up","volume":"1521","author":"Barreto","year":"2017","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.micpath.2024.107092_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/bmc.3552","article-title":"Validation of a sensitive HPLC\/fluorescence method for assessment of ciprofloxacin levels in plasma and prostate microdialysate samples from rats","volume":"30","author":"Zimmermann","year":"2015","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.micpath.2024.107092_bib23","doi-asserted-by":"crossref","first-page":"E600","DOI":"10.1208\/aapsj070362","article-title":"Lung microdialysis\u2014a powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)","volume":"7","author":"Zeitlinger","year":"2005","journal-title":"AAPS J."},{"year":"2023","key":"10.1016\/j.micpath.2024.107092_bib24"},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2024.107092_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/jac\/dkt028","volume":"68","author":"Zelenitsky","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2024.107092_bib26","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1183\/09031936.97.10051130","article-title":"Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes","volume":"10","author":"Sch\u00fcler","year":"1997","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.micpath.2024.107092_bib27","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.3390\/molecules14072535","article-title":"Bacterial extracellular polysaccharides involved in biofilm formation","volume":"14","author":"Vu","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.micpath.2024.107092_bib28","series-title":"Tratado de Animais Selvagens","first-page":"1215","article-title":"Terap\u00eautica por extrapola\u00e7\u00e3o alom\u00e9trica","author":"Patchaly","year":"2006"},{"key":"10.1016\/j.micpath.2024.107092_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14061237","article-title":"Probability of target attainment of tobramycin treatment in acute and chronic Pseudomonas aeruginosa lung infection based on preclinical population pharmacokinetic modeling","volume":"14","author":"Dias","year":"2022","journal-title":"Pharmaceutics"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102400559X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102400559X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T21:20:27Z","timestamp":1733952027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102400559X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"alternative-id":["S088240102400559X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2024.107092","relation":{},"ISSN":["0882-4010"],"issn-type":[{"type":"print","value":"0882-4010"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can distinct Gram-negative biofilm-forming bacteria have different impacts on ciprofloxacin lung penetration?","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2024.107092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107092"}}